Thankfully, there are currently two RSV vaccines approved by the Food and Drug Administration to help people protect against the virus: Arexvy by GlaxoSmithKline and ... details may vary depending on ...

GSK cut its full-year vaccine sales outlook after key shots for respiratory syncytial virus and shingles missed expectations ...

When it comes to surveillance, PHAC said provincial and territorial public health agencies must report both “confirmed and ...

Clinical study reports for the FURI, CARES and NATURE trials in refractory or resistant invasive fungal infections were delivered to GSK, ...

GSK cautions investors that any forward-looking statements or ... If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third ...

There are no indications that H5N1 bird flu would spark a pandemic, but experts urged preparedness including stockpiling vaccines and using wastewater testing.

Actuate’s lead investigational drug product, elraglusib (a novel GSK-3β inhibitor), targets molecular pathways ... or to reflect the occurrence of unanticipated events. Investor Contact Mike Moyer ...

Each year, up to 160,000 older adults living in the United States are hospitalized and as many as 10,000 die due to respiratory syncytial virus (RSV). RSV is a highly contagious virus that spreads ...

Experts and health authorities say that while the risk of human infection with the H5N1 strain of avian influenza remains low ...